RASSF8 and neoplasm: On the contrary, RASSF8 and RASSF10 have been shown to be reduced in multiple cancers, including lung cancer, gastric cancer, cervical cancer, breast cancer, colorectal esophageal squamous cell carcinoma, and hepatocarcinoma, and thus are considered as tumor suppressors [12–21].